Collegium Pharmaceutical Insider Trades
NASDAQ: COLLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 11 · $4.38M
- Shares bought / sold
- 0 / 108.77K
- Net activity
- Net selling $4.4 million
Collegium Pharmaceutical insider activity
Over the last 12 months, Collegium Pharmaceutical insiders reported 42 transactions on SEC Form 4: 0 open-market purchases and 11 sales. Insiders bought $0 and sold $4.4 million worth of stock, for net insider selling of $4.4 million. The largest seller was Dreyer Scott, with $2.9 million in reported sales.
The most recent filing shows Karnani Vikram (President and CEO) reporting a transaction in 11,737 shares at $24.95 on Nov 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put COLL's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
COLL insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 12, 2026 | Karnani VikramPresident and CEO | Tax withholding | 11,737 | $292.84K | Form 4 |
| Jun 8, 2026 | SANTINI GINODirector | Option exercise | 8,700 | $143.46K | Form 4 |
| May 18, 2026 | Freund John GordonDirector | Sale | 20 | $681 | Form 4 |
| May 15, 2026 | Freund John GordonDirector | Sale | 4,127 | $142.55K | Form 4 |
| May 15, 2026 | Freund John GordonDirector | Option exercise | 8,700 | $143.46K | Form 4 |
| May 14, 2026 | SANTINI GINODirector | Award | 8,741 | — | Form 4 |
| May 14, 2026 | BOHLIN GAREN GDirector | Award | 8,741 | — | Form 4 |
| May 14, 2026 | Glancy Donovan MichaelDirector | Award | 17,482 | — | Form 4 |
| May 14, 2026 | Lurker NancyDirector | Award | 8,741 | — | Form 4 |
| May 14, 2026 | Balice-Gordon Rita J.Director | Award | 8,741 | — | Form 4 |
| May 14, 2026 | Freund John GordonDirector | Award | 8,741 | — | Form 4 |
| May 14, 2026 | Paya Carlos VDirector | Award | 8,741 | — | Form 4 |
| May 13, 2026 | Lurker NancyDirector | Sale | 4,500 | $161.86K | Form 4 |
| May 11, 2026 | BOHLIN GAREN GDirector | Sale | 8,700 | $323.49K | Form 4 |
| May 11, 2026 | BOHLIN GAREN GDirector | Option exercise | 8,700 | $143.46K | Form 4 |
| Mar 18, 2026 | Dieter DavidEVP & General Counsel | Sale | 13,976 | $488.10K | Form 4 |
| Mar 17, 2026 | Dieter DavidEVP & General Counsel | Tax withholding | 8,840 | $315.76K | Form 4 |
| Mar 9, 2026 | Dieter DavidEVP & General Counsel | Sale | 6,224 | $228.11K | Form 4 |
| Mar 3, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Sale | 3,559 | $145.88K | Form 4 |
| Mar 3, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Sale | 46,417 | $1.87M | Form 4 |
| Feb 10, 2026 | Tupper ColleenEVP & Chief Financial Officer | Tax withholding | 26,679 | $1.25M | Form 4 |
| Feb 10, 2026 | Tupper ColleenEVP & Chief Financial Officer | Tax withholding | 11,861 | $554.50K | Form 4 |
| Feb 10, 2026 | Tupper ColleenEVP & Chief Financial Officer | Award | 32,734 | — | Form 4 |
| Feb 10, 2026 | Tupper ColleenEVP & Chief Financial Officer | Award | 26,421 | — | Form 4 |
| Feb 10, 2026 | Smith Thomas BEVP and Chief Medical Officer | Tax withholding | 11,538 | $539.40K | Form 4 |
| Feb 10, 2026 | Smith Thomas BEVP and Chief Medical Officer | Tax withholding | 5,897 | $275.68K | Form 4 |
| Feb 10, 2026 | Smith Thomas BEVP and Chief Medical Officer | Award | 22,774 | — | Form 4 |
| Feb 10, 2026 | Smith Thomas BEVP and Chief Medical Officer | Award | 14,268 | — | Form 4 |
| Feb 10, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Tax withholding | 21,615 | $1.01M | Form 4 |
| Feb 10, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Tax withholding | 9,977 | $466.42K | Form 4 |
| Feb 10, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Award | 30,702 | — | Form 4 |
| Feb 10, 2026 | Dreyer ScottEVP & Chief Commercial Officer | Award | 19,023 | — | Form 4 |
| Feb 10, 2026 | Karnani VikramPresident and CEO | Tax withholding | 11,296 | $528.09K | Form 4 |
| Feb 10, 2026 | Karnani VikramPresident and CEO | Award | 32,531 | — | Form 4 |
| Feb 10, 2026 | Karnani VikramPresident and CEO | Award | 79,264 | — | Form 4 |
| Feb 10, 2026 | Dieter DavidEVP & General Counsel | Tax withholding | 2,781 | $130.01K | Form 4 |
| Feb 10, 2026 | Dieter DavidEVP & General Counsel | Award | 9,005 | — | Form 4 |
| Feb 10, 2026 | Dieter DavidEVP & General Counsel | Award | 22,194 | — | Form 4 |
| Dec 8, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Sale | 6,475 | $315.08K | Form 4 |
| Dec 8, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Sale | 11,125 | $532.77K | Form 4 |
| Dec 8, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Option exercise | 17,600 | $279.84K | Form 4 |
| Dec 5, 2025 | Balice-Gordon Rita J.Director | Sale | 3,650 | $171.67K | Form 4 |
| Nov 12, 2025 | Fallon John A.Director | Sale | 34,853 | $1.65M | Form 4 |
| Nov 12, 2025 | Fallon John A.Director | Option exercise | 19,853 | $185.23K | Form 4 |
| Nov 12, 2025 | Fallon John A.Director | Option exercise | 15,000 | $247.35K | Form 4 |
| Nov 12, 2025 | Karnani VikramPresident and CEO | Tax withholding | 8,983 | $425.35K | Form 4 |
| Nov 6, 2025 | Tupper ColleenEVP & Chief Financial Officer | Sale | 4,858 | $200.52K | Form 4 |
| Nov 6, 2025 | Tupper ColleenEVP & Chief Financial Officer | Sale | 25,142 | $1.02M | Form 4 |
| Aug 29, 2025 | Smith Thomas BEVP and Chief Medical Officer | Sale | 17,478 | $671.58K | Form 4 |
| Aug 18, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Sale | 16,389 | $626.17K | Form 4 |
| Aug 18, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Option exercise | 16,389 | $349.74K | Form 4 |
| Aug 15, 2025 | SANTINI GINODirector | Sale | 5,405 | $201.02K | Form 4 |
| Aug 15, 2025 | SANTINI GINODirector | Option exercise | 15,000 | $201.75K | Form 4 |
| Aug 13, 2025 | Rubric Capital Management LP & Rosen David Efraim10% Owner | Sale | 25,000 | $946.25K | Form 4 |
| Aug 13, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Sale | 4,861 | $184.88K | Form 4 |
| Aug 13, 2025 | Dreyer ScottEVP & Chief Commercial Officer | Option exercise | 4,861 | $103.73K | Form 4 |
| Aug 8, 2025 | Freund John GordonDirector | Sale | 11,659 | $400.64K | Form 4 |
| Jun 9, 2025 | Freund John GordonDirector | Sale | 6,601 | $202.15K | Form 4 |
| Jun 9, 2025 | Freund John GordonDirector | Option exercise | 15,000 | $201.75K | Form 4 |
| May 15, 2025 | Paya Carlos VDirector | Award | 19,582 | — | Form 4 |
| May 15, 2025 | BOHLIN GAREN GDirector | Award | 9,791 | — | Form 4 |
| May 15, 2025 | Fallon John A.Director | Award | 9,791 | — | Form 4 |
| May 15, 2025 | SANTINI GINODirector | Award | 9,791 | — | Form 4 |
| May 15, 2025 | Freund John GordonDirector | Award | 9,791 | — | Form 4 |
| May 15, 2025 | Balice-Gordon Rita J.Director | Award | 9,791 | — | Form 4 |
| May 15, 2025 | Lurker NancyDirector | Award | 9,791 | — | Form 4 |
| Mar 21, 2025 | Tupper ColleenEVP & Chief Financial Officer | Sale | 6,396 | $192.07K | Form 4 |
| Mar 20, 2025 | Tupper ColleenEVP & Chief Financial Officer | Sale | 1,206 | $36.18K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4